V03.250

2 trials

Sponsors

GlaxoSmithKline Brasil, Faculdade de Ciências Médicas da Santa Casa de São Paulo

Conditions

Diabetes mellitusNeoplasms, breast cancer HER2 positive

Phase 2

Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer

RecruitingRBR-58ghgp

GlaxoSmithKline BrasilNeoplasms, breast cancer HER2 positive

Start: 2016-01-04Updated: 2025-10-27

Unknown Phase

The role of technology in obeying different types of treatment of insulin-dependent diabetes mellitus

Active, not recruitingRBR-6qx7m5

Faculdade de Ciências Médicas da Santa Casa de São PauloDiabetes mellitus

Start: 2019-01-28Updated: 2025-10-27